3.0.0 2570 2025-05-27T14:16:51Z 2025-05-27T14:16:51Z House H HR 2023-04-10 118 <pre>[Congressional Record Volume 169, Number 61 (Monday, April 10, 2023)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. PFLUGER:H.R. 2570.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8The single subject of this legislation is:This bill requires more accurate reporting of abortion drugprescribing and related adverse events, and for otherpurposes.[Page H1719]</pre> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2023-04-21T18:06:41Z Referred To 2023-04-10T18:01:20Z 2023-04-21 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2023-04-10 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2023-04-10 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-04-10 Introduced in House IntroReferral 1000 9 Library of Congress P000048 Rep. Pfluger, August [R-TX-11] August Pfluger R TX 11 N H001067 Rep. Hudson, Richard [R-NC-9] Richard Hudson R NC 9 2023-04-10 True B001309 Rep. Burchett, Tim [R-TN-2] Tim Burchett R TN 2 2023-04-18 False Health Health 2023-04-19T19:45:17Z

00 2023-04-10 Introduced in House 2023-11-21T18:50:47Z <p><strong>Safeguarding Women's and Children's Health Act of </strong><b>2023</b></p> <p>This bill imposes reporting requirements relating to abortion drugs.</p> <p>The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug. </p> <p>The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events. </p> <p>The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use. </p>

Display Title 45 2024-07-24T15:22:52Z Short Title(s) as Introduced 101 2024-05-24T13:41:04Z Introduced in House IH Official Title as Introduced 6 2024-03-18T20:36:24Z Introduced in House IH Introduced in House 2023-04-10T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr2570ih/xml/BILLS-118hr2570ih.xml 2023-04-21 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.